M&A news

ZEISS Vision Completes Acquisition of Ocumeda to Expand Vision Care

Ocumeda acquired by ZEISS Vision

AcquisitionHealthcare

Get the full Ocumeda company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Ocumeda logo
Acquired

Ocumeda

Medical Device

Undisclosed amount

October 1, 2025

ZEISS Vision logo
Acquirer

ZEISS Vision

Medical Equipment Manufacturing

ZEISS Vision has acquired Ocumeda for an undisclosed amount. Ocumeda specializes in making preventative eye care accessible, offering teleophthalmological eye check-ups through a network of opticians and experienced ophthalmologists. Its services aim to prevent blindness and vision impairment by providing timely, affordable, and convenient screenings, where trained personnel at partner opticians conduct measurements and retinal imaging for remote evaluation by specialists.

The acquisition is a strategic move for ZEISS Vision, a company known for its optical technology and vision care solutions. By integrating Ocumeda’s innovative teleophthalmology platform, ZEISS Vision aims to expand its portfolio beyond traditional optical products and equipment. This move allows ZEISS to enter the growing segment of advanced diagnostic and preventative eye care services, addressing the increasing demand for early detection of serious eye conditions.

This acquisition is expected to generate significant synergies. Ocumeda's established model of decentralized eye screening locations and its efficient tele-medical evaluation process will complement ZEISS Vision’s technological expertise and broad market presence. The combined entity can enhance the accessibility and quality of eye health services, leveraging ZEISS’s resources to scale Ocumeda’s preventative care model and further integrate diagnostic capabilities into the wider vision care ecosystem.

Looking ahead, the integration of Ocumeda into ZEISS Vision is anticipated to strengthen ZEISS’s position as a comprehensive provider in the global vision care market. This combined capability is expected to improve patient outcomes by facilitating earlier intervention for eye diseases and offering a more integrated approach to vision health management. The focus will remain on delivering advanced, accessible solutions for preventing vision impairment worldwide.

Buying signals & intent

Our AI suggests Ocumeda may be interested in:

Augenärzte
Augenoptiker
Medizinische Dienstleistungen
Gesundheitsversorgung
Telemedizin-Plattformen

Unlock GTM signals

Discover Ocumeda's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Ocumeda.

Unlock decision-makers